Krstevska V, Stojkovski I, Zafirova-Ivanova B
Department of Head and Neck Cancer, University Clinic of Radiotherapy and Oncology, Faculty of Medicine, Skopje, FYROMakedonia.
J BUON. 2010 Oct-Dec;15(4):690-7.
the aim of this retrospective study was to evaluate the frequency of distant metastases (DM) and to define factors that influence DM free survival (DMFS) in patients with head and neck squamous cell carcinoma (HNSCC).
the charts of 201 patients with oral cavity, pharyngeal, or laryngeal carcinoma, treated with postoperative radiotherapy (RT) or definitive RT between 1999 and 2004 and achieved locoregional control were analyzed.
DM occurred in 26 of 201 (12.9%) patients. The mean time of DM diagnosis was 16.5 months (range 5-35). The median time to death after diagnosis of DM was 5 months (range 1-13). The DMFS rate at 5 years was 84.8%. Univariate analysis demonstrated that the risk of DM was significantly influenced by age (p=0.047), cigarette smoking (p=0.024), ECOG performance status (PS) (p=0.008), location of the primary site (p=0.003), N stage (p<0.0001), overall stage (p<0.0001), histological differentiation (p<0.0001), levels of nodal involvement (p<0.0001), treatment modality (p<0.0002), presence of locoregional recurrence (LRR) (p<0.0001), and time to LRR (p<0.0001). In multivariate analysis nodal involvement (N1: p=0.007; N2: p=0.036; N3: p=0.043), and the time to LRR ≤ 6 months (p=0.037) were proven as independent factors that significantly influenced DMFS.
development of DM in patients with HNSCC was significantly influenced by the presence of positive nodal status and the presence of LRR whose appearance was within 6 months of RT.
本回顾性研究旨在评估远处转移(DM)的发生率,并确定影响头颈部鳞状细胞癌(HNSCC)患者无远处转移生存期(DMFS)的因素。
分析了201例口腔、咽或喉癌患者的病历,这些患者在1999年至2004年间接受了术后放疗(RT)或根治性放疗并实现了局部区域控制。
201例患者中有26例(12.9%)发生DM。DM诊断的平均时间为16.5个月(范围5 - 35个月)。DM诊断后至死亡的中位时间为5个月(范围1 - 13个月)。5年时的DMFS率为84.8%。单因素分析表明,DM风险受年龄(p = 0.047)、吸烟(p = 0.024)、美国东部肿瘤协作组体能状态(PS)(p = 0.008)、原发部位(p = 0.003)、N分期(p < 0.0001)、总分期(p < 0.0001)、组织学分化(p < 0.0001)、淋巴结受累程度(p < 0.0001)、治疗方式(p < 0.0002)、局部区域复发(LRR)的存在(p < 0.0001)以及至LRR的时间(p < 0.0001)的显著影响。多因素分析表明,淋巴结受累(N1:p = 0.007;N2:p = 0.036;N3:p = 0.043)以及至LRR的时间≤6个月(p = 0.037)被证明是显著影响DMFS的独立因素。
HNSCC患者发生DM受阳性淋巴结状态的存在以及放疗后6个月内出现的LRR的显著影响。